» Articles » PMID: 34757385

Laparoscopic Versus Open Resection of Hepatocellular Carcinoma in Patients with Cirrhosis: Meta-analysis

Overview
Journal Br J Surg
Specialty General Surgery
Date 2021 Nov 10
PMID 34757385
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The exact role of laparoscopic liver resection (LLR) in patients with hepatocellular carcinoma (HCC) and underlying liver cirrhosis (LC) is not well defined. In this meta-analysis, both long- and short-term outcomes following LLR versus open liver resection (OLR) were analysed.

Methods: PubMed, EMBASE, Scopus and Web of Science databases were searched systematically for randomised controlled trials (RCTs) and propensity-score matched (PSM) studies reporting outcomes of LLR versus OLR of HCC in patients with cirrhosis. Primary outcome was overall survival (OS). This was analysed using one-stage (individual participant data meta-analysis) and two-stage (aggregate data meta-analysis) approaches. Secondary outcomes were operation duration, blood loss, blood transfusion, Pringle manoeuvre utilization, overall and major complications, length of hospital stay (LOHS), 90-day mortality and R0 resection rates.

Results: Eleven studies comprising 1618 patients (690 LLR versus 928 OLR) were included for analysis. In the one-stage meta-analysis, an approximately 18.7 per cent lower hazard rate (HR) of death in the LLR group (random effects: HR 0.81, 95 per cent confidence interval [C.I.] 0.68 to 0.96; P = 0.018) was observed. Two-stage meta-analysis resulted in a pooled HR of 0.84 (95 per cent C.I. 0.74 to 0.96; P = 0.01) in the overall LLR cohort. This indicated a 16-26 per cent reduction in the HR of death for patients with HCC and cirrhosis who underwent LLR. For secondary outcomes, LLR was associated with less blood loss (mean difference [MD] -99 ml, 95 per cent C.I. -182 to -16 ml), reduced overall complications (odds ratio 0.49, 95 per cent C.I. 0.37 to 0.66) and major complications (odds ratio 0.45, 95 per cent C.I. 0.26 to 0.79), and shorter LOHS (MD -3.22 days, 95 per cent C.I. -4.38 to -2.06 days).

Conclusion: Laparoscopic resection of HCC in patients with cirrhosis is associated with improved survival and perioperative outcomes.

Citing Articles

Safety of local thermal ablation in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia.

Zhao F, Zhang T, Yang Q, Zhang X, Yang F, Qian N Sci Rep. 2024; 14(1):28350.

PMID: 39550438 PMC: 11569221. DOI: 10.1038/s41598-024-79416-w.


Impact of metabolic dysfunction-associated fatty liver disease on the outcomes following laparoscopic hepatectomy for hepatocellular carcinoma.

Xu H, Liu Y, Wei Y Surg Endosc. 2024; 38(11):6456-6463.

PMID: 39266759 DOI: 10.1007/s00464-024-11239-2.


Multilayered insights: a machine learning approach for personalized prognostic assessment in hepatocellular carcinoma.

Zhang Z, Du Y, Wei S, Pei W Front Oncol. 2024; 13:1327147.

PMID: 38486931 PMC: 10937467. DOI: 10.3389/fonc.2023.1327147.


Robotic Complete ALPPS (rALPPS)-First German Experiences.

Arend J, Franz M, Rose A, March C, Rahimli M, Perrakis A Cancers (Basel). 2024; 16(5).

PMID: 38473426 PMC: 10930461. DOI: 10.3390/cancers16051070.


What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?.

Vitale A, Angelico R, Sensi B, Lai Q, Kauffmann E, Scalera I Cancers (Basel). 2024; 16(5).

PMID: 38473327 PMC: 10930835. DOI: 10.3390/cancers16050966.